JoshuaMichaelLarnedMD

PubMed

• 1 citations
  Guideline-based and restricted fluid resuscitation strategy in sepsis patients with heart failure: A systematic review and meta-analysis.
  Alan Wong, Andrew Carl Crawford, Elias Collado, Joshua M Larned, Vaeli Zadeh, A., Ali Vaeli Zadeh> ;The American Journal of Emergency Medicine. 2023 Nov 1
• Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant.
  Cannon CP, Kim JM, Lee JJ, Sutherland J, Bachireddy R, Valentine CM, Hearne S, Trebnick A, Jaffer S, Datta S, Semmel E, Thorpe F, Doros G, Cavender MA, Reynolds MR, Be...> ;JAMA network open. 2023-04-03
• Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
  Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ, TRA...> ;JAMA.
• Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
  Bohula EA, Berg DD, Lopes MS, Connors JM, Babar I, Barnett CF, Chaudhry SP, Chopra A, Ginete W, Ieong MH, Katz JN, Kim EY, Kuder JF, Mazza E, McLean D, Mosier JM, Mosk...> ;Circulation. 2022-08-29
• Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
  Shah SJ, Borlaug BA, Chung ES, Cutlip DE, Debonnaire P, Fail PS, Gao Q, Hasenfuß G, Kahwash R, Kaye DM, Litwin SE, Lurz P, Massaro JM, Mohan RC, Ricciardi MJ, Solomon ...> ;Lancet (London, England). 2022-02-01
• Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial.
  Lam CSP, Giczewska A, Sliwa K, Edelmann F, Refsgaard J, Bocchi E, Ezekowitz JA, Hernandez AF, O'Connor CM, Roessig L, Patel MJ, Pieske B, Anstrom KJ, Armstrong PW, VIC...> ;JAMA cardiology.
• Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fract...
  Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP, Ponikowski P, Shah SJ, Solomon SD, Kraigher-Krainer E, Samano ET, Müller K, Roessig L, Pieske B,...> ;JAMA.
• Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute...
  Pang PS, Mehra M, Maggioni AP, Filippatos G, Middlebrooks J, Turlapaty P, Kazei D, Gheorghiade M, RENO-DEFEND Investigators> ;American heart journal.
• Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
  Greene SJ, Velazquez EJ, Anstrom KJ, Eisenstein EL, Sapp S, Morgan S, Harding T, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Mentz RJ, TRANSFORM-HF Invest...> ;JACC. Heart failure. 2021-03-10
• Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
  Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM...> ;The New England journal of medicine. 2020-03-28
• Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
  Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E, PIONEER-HF Investigators> ;The New England journal of medicine. 2018-11-11
• Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES).
  Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski P, Shah S, Solomon S, Kraigher-Krainer E, Samano ET, Scalise AV, Müller K, Roessig L, Gheorghiade M, S...> ;European journal of heart failure. 2014-07-24
• 15 citations
  Atrial fibrillation and heart failure.
  Joshua M Larned, S. Raja Laskar> ;Congestive Heart Failure. 2009 Jan 1
• 3 citations
  Clues to Cardiovascular Risk: An Office‐Based Approach
  Andrew P. DeFilippis, Joshua M. Larned, Jason H Cole, Christine Nell-Dybdahl, Joseph I. Miller, Laurence S. Sperling> ;Preventive Cardiology. 2007 Jan 1
• 50 citations
  Vitamin A Levels and Immunity in Humans
  Janine Jason, Lennox K. Archibald, Okey C. Nwanyanwu, Anne L. Sowell, Ian Buchanan, Joshua Larned, Michael Bell, Peter N. Kazembe, Hamish Dobbie, William R. Jarvis> ;Clinical and Diagnostic Laboratory Immunology. 2002 May 1
• 54 citations
  Cytokines and malaria parasitemia
  Janine Jason, Lennox K. Archibald, Okey C. Nwanyanwu, Michael Bell, Ian Buchanan, Joshua Larned, Peter N. Kazembe, Hamish Dobbie, Bharat Parekh, Martha G. Byrd, Angeli...> ;Clinical Immunology. 2001 Aug 1
• 13 citations
  Immune determinants of organism and outcome in febrile hospitalized Thai patients with bloodstream infections.
  Janine Jason, Lennox K. Archibald, L. Clifford McDonald, W. Michael Hart, Sunthorn Rheanppumikankit, Somsit Tansuphwaswadikul, Martha G. Byrd, Joshua Larned, Alison Ha...> ;Clinical and Diagnostic Laboratory Immunology. 1999 Jan 1
• Single-cell cytokine profiles in normal humans: comparison of flow cytometric reagents and stimulation protocols.
  Jason, J., Larned, J.> ;J Immunol Methods. 1997 Aug 22
• Effects of HIV-1 peptides on T-cell receptor variable beta chain families.
  Eick, A., Larned, J., Jason, J.> ;Hum Immunol. 2000 Oct
• The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost.
  Jason, J., Archibald, L. K., Nwanyanwu, O. C., Bell, M., Jensen, R. J., Gunter, E., Buchanan, I., Larned, J., Kazembe, P. N., Dobbie, H., Jarvis, W. R.> ;Clin Exp Immunol. 2001 Dec
• Join now to see all